Acorda Therapeutics Inc., of Ardsley, N.Y., disclosed in an SEC filing that the U.S. Court of Appeals for the Federal Circuit denied per curiam the company's motion for an injunction pending a decision in its appeal of a U.S. District Court decision in patent litigation with certain generic drug manufacturers.